EUVIMEDEUVIMED entdecken
Crossref

Clonal hematopoiesis in large granular lymphocytic leukemia

Naomi Kawashima, Carmelo Gurnari, Carlos Bravo-Perez, Yasuo Kubota, Simona Pagliuca, Luca Guarnera, Nakisha D Williams, Arda Durmaz, Arooj Ahmed, Danai Dima, Fauzia Ullah, Hetty E Carraway und 3 weitere

Leukemia · 2025

DOI: 10.1038/s41375-024-02460-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Leukemia, 2025. Verfasst von Naomi Kawashima und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, Leukemia, Large Granular Lymphocytic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI), Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III), Aplastic Anemia and MDS International Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Past studies described occasional patients with myeloid neoplasms (MN) and coexistent large granular lymphocytic leukemia (LGLL) or T-cell clonopathy of unknown significance (TCUS), which may represent expansion of myeloid clonal hematopoiesis (CH) as triggers or targets of clonal cytotoxic T cell reactions. We retrospectively analyzed 349 LGLL/TCUS patients, 672 MN patients, and 1443 CH individuals to establish the incidence, genetic landscape, and clinical phenotypes of CH in LGLL. We identified 8% of cases overlapping with MN, while CH was found in an additional 19% of cases (CH + /LGLL) of which TET2 (23%) and DNMT3A (14%) were the most common. In MN cohort, 3% of cases showed coexistent LGLL. The incidence of CH in LGLL was exceedingly higher than age-matched CH controls (P < 0.0001). By multivariate analysis, the presence of CH in LGLL (P = 0.026) was an independent risk factor for cytopenia in addition to older age (P = 0.003), splenomegaly (P = 0.015) and STAT3/5B mutations (P = 0.001). CH + /LGLL cases also showed a higher progression rate to MN than CH-/LGLL (10% vs. 2% at 5 years; P = 0.02). A close relationship between CH and LGLL suggests that cytopenia in LGLL may be not only related to LGLL but be also secondary to coexisting clonal cytopenia of unclear significance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisLeukemia, Large Granular LymphocyticHumansMaleFemaleAgedMiddle AgedRetrospective StudiesAged, 80 and overMutationAdultDNA Methyltransferase 3ADioxygenasesPrognosis

Substanzen

DNA Methyltransferase 3ADioxygenasesDNMT3A protein, human

Autor:innen und Institutionen

  • Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
  • Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain.
  • Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Clinical Hematology, CHRU de Nancy, Nancy, France.
  • Department of Hematology Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

Förderung

  • U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
  • Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III)
  • Aplastic Anemia and MDS International Foundation
  • Uehara Memorial Foundation
  • Astellas Foundation for Research on Metabolic Disorders
  • Edward P. Evans Foundation
  • Case Comprehensive Cancer Center, Case Western Reserve University

Zitieren

APA

Kawashima, N., Gurnari, C., Bravo-Perez, C., Kubota, Y., Pagliuca, S., Guarnera, L., Williams, N. D., Durmaz, A., Ahmed, A., Dima, D., Ullah, F., Carraway, H. E., Singh, A., Visconte, V., & Maciejewski, J. P. (2025). Clonal hematopoiesis in large granular lymphocytic leukemia. Leukemia. https://doi.org/10.1038/s41375-024-02460-y

Vancouver

Kawashima N, Gurnari C, Bravo-Perez C, Kubota Y, Pagliuca S, Guarnera L, et al. Clonal hematopoiesis in large granular lymphocytic leukemia. Leukemia. 2025. doi:10.1038/s41375-024-02460-y

BibTeX
@article{Kawashima2025,
  author = {Kawashima, Naomi and Gurnari, Carmelo and Bravo-Perez, Carlos and Kubota, Yasuo and Pagliuca, Simona and Guarnera, Luca and Williams, Nakisha D and Durmaz, Arda and Ahmed, Arooj and Dima, Danai and Ullah, Fauzia and Carraway, Hetty E and Singh, Abhay and Visconte, Valeria and Maciejewski, Jaroslaw P},
  title = {Clonal hematopoiesis in large granular lymphocytic leukemia},
  journal = {Leukemia},
  year = {2025},
  doi = {10.1038/s41375-024-02460-y}
}
Kostenlos starten →